Loading...
XSHE
300757
Market cap12bUSD
Oct 09, Last price  
504.00CNY
1D
-0.79%
1Q
3.07%
IPO
1,818.03%
Name

RoboTechnik Intelligent Technology Co Ltd

Chart & performance

D1W1MN
XSHE:300757 chart
P/E
—
P/S
88.94
EPS
—
Div yield, %
0.01%
Shrs. gr., 5y
10.02%
Rev. gr., 5y
12.45%
Revenues
950m
-14.14%
19,560,922117,593,365297,024,280428,862,172658,584,895981,033,594528,248,9711,085,951,105903,197,5291,571,536,8431,106,297,340949,812,665
Net income
-66m
L
-5,157,15721,397,43547,499,19686,920,57995,325,85799,880,994-67,270,672-46,875,28926,141,99277,132,77263,885,465-66,440,373
CFO
208m
P
-7,457,400032,367,00039,373,642-9,095,000-77,451,000-104,845,000-178,126,000268,963,000-27,899,000-317,157,000207,795,147
Dividend
Aug 27, 20250.045 CNY/sh

Notes

No notes on this company yet
Write a private note on this company, for your eyes only

Profile

RoboTechnik Intelligent Technology Co., LTD, based in Suzhou, China, is a company focused on the creation, production, and sale of advanced automation solutions for intelligent manufacturing environments. Their comprehensive portfolio includes Manufacturing Execution Systems (MES) and a variety of specialized clean energy systems, such as automated processes for diffusion, PECVD, testing, sorting, and wet processing. The company also engineers and provides assembly and testing lines tailored for a wide range of components, including motor brushes, transformer coils, various pumps (oil and water), control valves (oil, solenoid, VVT intake/exhaust, and central), and valve bodies. Furthermore, their product offerings extend to smart racking and storage systems, laser cutting technology, and a full suite of automation solutions for Flexible Printed Circuits (FPC), encompassing layup, sorting, PSA application, and multi-functional testing. They also supply product unloading machines and automated packaging systems, notably for bagged milk. RoboTechnik's innovative solutions cater to key industrial sectors such as clean energy, electronics and semiconductors, automotive, food processing, and pharmaceuticals.

Key people

Jun Dai
Chairman of the Board, Chief Executive Officer · since 2019
Yang Liu
Chief Financial Officer · since 2025
Weibin Li
Chief Operating Officer, Vice President · since 2025
Liangyu Li
Secretary of the Board · since 2021
Torsten Vahrenkamp
Director · since 2025
Huaqiao Zhu
Staff Elected Director · since 2025
Independent Director · since 2022
Xufeng Ling
Independent Director · since 2024
Zhaobin Zhu
Independent Director · since 2022
IPO date
Jan 08, 2019
Employees
Domiciled in
CN
Incorporated in
CN

Valuation

Title
CNY in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFYFYFY
2025‑122024‑122023‑122022‑122021‑122020‑122019‑122018‑122017‑122016‑12
Income
Revenues
Cost of revenue
Unusual Expense (Income)
NOPBT
NOPBT Margin
Operating Taxes
Tax Rate
NOPAT
Net income
Dividends
Dividend yield
Proceeds from repurchase of equity
BB yield
Debt
Debt current
Long-term debt
Deferred revenue
Other long-term liabilities
Net debt
Cash flow
Cash from operating activities
CAPEX
Cash from investing activities
Cash from financing activities
FCF
Balance
Cash
Long term investments
Excess cash
Stockholders' equity
Invested Capital
ROIC
ROCE
EV
Common stock shares outstanding
Price
Market cap
EV
EBITDA
EV/EBITDA
Interest
Interest/NOPBT